Call us on+91-7807096339
Get a Quote

Welcome to Biozenta

Biozenta has laid its foundation in year 2018 with a noble intention to provide critical care medicines at an affordable cost enabling every human being to live healthier, happier and more active life.

In short, span of time, Biozenta became a trusted name in global pharmaceutical industry as a leading manufacturer of best quality product in Oncology and critical care segment.

Biozenta is one of the leading and fastest growing pharmaceutical and life science group of companies with its presence in multiple therapy segment like Oncology/Cytotoxic and Critical Care/lifesaving medicines.

Biozenta strongly believe that research and innovation led product portfolio is the mainstay of organization. Biozenta keeps firm commitment towards quality and continuous innovation. Biozenta has established DSIR approved R&D set up for formulation as well as API to strengthen capability of innovative and research driven manufacturing facility.

Biozenta plant are equipped with state of art, WHO cGMP Certified, PICS approved, EU GMP approvable facilities located in one of the strategic pharmaceutical zone of Una, Himachal Pradesh. At an early stage, Biozenta Leadership identified the need for achieving self-sufficiency in formulation by vertically integrating its API Plant commissioned to cater API needs

Please have a glimpse on ultra-modern manufacturing facility dedicated for the production of Generic and Branded formulation in Oncology and Critical Care segment:

  • Oncology Facility - Well equipped, Dedicated, completely isolated & separate unit at UNA, H.P, covers all the major dosage forms in Oncology/ Anti-cancer/ Cytotoxic range - Liquid Injectables, Lyophilized Injectables, Pre-filled Syringes (PFS) & Oral Solids-Tablets and Capsules.
  • General Facility – Stand-alone & separate unit at UNA, H.P, covering all major dosage forms of Liquid Injectables, Lyophilized Injectable, Pre-filled Syringes (PFS) & Oral Solids - Tablets and Capsules.
  • Active Pharmaceutical Ingredients Unit - Dedicated Oncology/Anti-cancer/Cytotoxic API and Intermediates facility located at UNA, H.P to make company self-sufficient with focus to improve the synthetic procedures, Quality & stability of the Raw materials.

Milestones:

2018

First
Milestone

Biozenta registered its company in Roorkee, Uttarakhand.

2019

Second
Milestone

Started its Oncology and Critical Care manufacturing Unit at UNA, H.P.

2021

Third
Milestone

Started manufacturing unit for General range Plant for Injectables, Lyophilized Injectables, PFS, Contrast Media and Oral Solids at UNA H.P.

2021

Fourth
Milestone

Established, "Biogracea Medicare", a c-GMP compliant manufacturing unit for “External Preparation Drugs and Cosmetics” at UNA, H. P.

2021

Fifth
Milestone

Started its unique RandD Lab with advanced technology for “MAB-development” (Monoclonal antibody) in Chandigarh.

2021

Sixth
Milestone

Started its corporate office at Mohali Punjab for Business Development Activities and Regulatory Support.

2023

Seventh
Milestone

Proudly received “PICs” approval for Oncology and General Range manufacturing Unit based at UNA, H.P.

2023

Eighth
Milestone

Inaugurated its new “Corporate office” as “Biozenta House” in Mumbai.

2023

Ninth
Milestone

Signed “Partnership deed with US partner for Biosimilar products” to be launched by 2024.

2023

Tenth
Milestone

"Launching into the Domestic Marketing Division" at Mohali, 2023.

2023

Eleventh
Milestone

Inaugurated its new “Corporate office” as “Biozenta, USA”

Leader in Innovation and Research.

Global flagship in manufacturing of critical segments of Oncological injectable preparations like Nano particle drugs, Liposomal preparations, Lyophilised and Prefilled Syringe PFS.

Download Products Brochure

Products

Management and Leadership

Dr. Deep Narayan Sharma, Founder and Managing Director of Biozenta group of companies is a sound technocrat and young, ambitious and dynamic leader. Completed his masters in pharmacy with MBA in Production Management having vast and sound experience in the field of Pharmaceutical manufacturing industry, is a first-generation entrepreneur of his family with lot of passion, focused approach and deep understanding of Oncology, Anti-cancer, Cytotoxic, Critical Care and Life Saving products with major focus on nano-particles and Liposomal technologies.

With 22+ years of experience in corporate industry at various levels including top management and his passion for Oncology, Anti-cancer, Cytotoxic, Critical Care and Life Saving products, he started his first venture in the year 2011 as Dr. Aarbidee Laboratories and Aarya Healthcare (A Division for Food Products) which has been later merged with Biozenta group in 2018.

Under the guiding principles and leadership of Dr. Deep Narayan Sharma, Biozenta achieved various new milestones and offered many innovative Oncology, Anti-cancer, Cytotoxic, Critical Care and Life Saving products.

Firm believer in hard work, self-belief, “walk the talk”, leading by examples, ambitious, innovative approach, “passion for work” are some of the key success factors which he wants to imbibe by every employee of the organization to achieve company’s vision of “Human Helping Human”

GLOBAL PRESENCE

Biozenta, a Indian Global Multinational Company:

Biozenta pursuing and exporting to over 30+ countries across the continents globally which include Asia, Africa, LATAM, CIS, MENA and Europe. With over 180+ international product registrations (many more are under registrations), Biozenta is emerging as one of the leading and fast growing major Indian pharmaceutical manufacturer and exporter. Biozenta is aggressively participating in all the Govt, MOH and local tenders of pharmaceutical formulations, across the globe.

Biozenta strives to be a world class pharmaceutical manufacturer for the development and providing high quality products with superior performance at affordable price. Biozenta’s formulation development and regulatory teams are focused on developing the latest generics to the global markets, with a commitment for continuous flow of innovative products across the globe, in all the therapeutic categories - Oncology, Anti-cancer, Cytotoxic, Critical-care, Life-saving, General Injectables, Contrast Media Injectables, Oral Solids - Tablets and Capsules – including Ant-retrovirals (ARVs), External Preparations – Derma and Cosmetics and also vertically integrated for key Oncology Active Pharmaceutical Ingredients (API’s).

Our Branded and Generic medicines enjoy steady demand in following countries:

  • Asia
    Bangladesh, Bhutan, Nepal, Pakistan, Sri Lanka, Maldives, Cambodia, Myanmar, Philippines, Vietnam, Laos, Kazekhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, Russia, Mongolia, Azerbaijan, Georgia
  • Africa/Mena
    Algeria, Egypt, Jordan, Kuwait, Lebanon, Libya, Morocco, Yemen, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Ethiopia, Congo, Gambia, Ivory Coast, Angola, Mali
  • Caribbean
    Barbados, Dominican Republic, Jamaica, St. Lucia, St. Vincent and The Grenadines, Trinidad & Tobago, Antigua & Barbuda, Bahamas, Cuba, Dominica, Grenada, Haiti, Martinique, Puerto Rico.
  • North & South America
    Bolivia, Brazila, Belize, Chile, Colombia, Costarica, Ecuador, Guatemala, Honduras, Mexico, Panama, Peru, Paraguay, El Salvador, Suriname, Uruguay, Venezuela
  • Europe
    Belarus, Bulgaria, Moldova, Republic of Mecedonia, Ukraine
  • OCEANIA
    Fiji
  • GCC & Middle East
    Oman, Qatar, Saudi Arabia, United Arab Emirates.
Request A Call Back
Register Drug Shortage
Online Enquiry
Job Opportunities